{"version":"1.0","provider_name":"Crypto Insider","provider_url":"https:\/\/cryptoinsider.asia\/vi\/","author_name":"Crypto Insider","author_url":"https:\/\/cryptoinsider.asia\/vi\/author\/cryptoinsider\/","title":"Arch Biopartners Closes Non-Brokered Private Placement","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XYAYOW44yF\"><a href=\"https:\/\/cryptoinsider.asia\/vi\/arch-biopartners-closes-non-brokered-private-placement\/\">Arch Biopartners Closes Non-Brokered Private Placement<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/cryptoinsider.asia\/vi\/arch-biopartners-closes-non-brokered-private-placement\/embed\/#?secret=XYAYOW44yF\" width=\"600\" height=\"338\" title=\"&#8220;Arch Biopartners Closes Non-Brokered Private Placement&#8221; &#8212; Crypto Insider\" data-secret=\"XYAYOW44yF\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/cryptoinsider.asia\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/ml.globenewswire.com\/media\/YjA0NmQ3YTEtMTkxNy00YTQyLWJmNDctMjY3MDk2NGZjMTJhLTExMDUyMDgtMjAyNi0wNC0wMi1lbg==\/tiny\/Arch-Biopartners.png","thumbnail_width":1,"thumbnail_height":1,"description":"TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (\u201cArch\u201d or the \u201cCompany\u201d) (TSX Venture: ARCH and OTCQB: ACHFF) announced today it has closed a non-brokered private placement offering of 1,000,000 common shares priced at $0.60 per common share (the \u201cCommon Shares\u201d) for gross proceeds of $600,000 CAD (the \u201cOffering\u201d). The proceeds of the Offering will be used by Arch for general working capital and for certain operating expenses that are not covered by the Company\u2019s human trial funding..."}